{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T21:11:47Z","timestamp":1793481107407,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"36","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21-AI105605-01"],"award-info":[{"award-number":["R21-AI105605-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NR-3169"],"award-info":[{"award-number":["NR-3169"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["A\/Puerto Rico\/8\/1934"],"award-info":[{"award-number":["A\/Puerto Rico\/8\/1934"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["H1N1"],"award-info":[{"award-number":["H1N1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003762","name":"Institut Pasteur","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.vaccine.2019.07.033","type":"journal-article","created":{"date-parts":[[2019,7,19]],"date-time":"2019-07-19T08:07:07Z","timestamp":1563523627000},"page":"5371-5381","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"title":["Highly conserved influenza T cell epitopes induce broadly protective immunity"],"prefix":"10.1016","volume":"37","author":[{"given":"Christopher S.","family":"Eickhoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances E.","family":"Terry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystal A.","family":"Meza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac G.","family":"Sakala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Van Aartsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard","family":"Moise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Schriewer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Mark","family":"Buller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne S.","family":"De Groot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel F.","family":"Hoft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.07.033_b0005","unstructured":"WHO. Fact sheet N\u00b0211 - Influenza (Seasonal); 2014."},{"key":"10.1016\/j.vaccine.2019.07.033_b0010","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMp058281","article-title":"The origins of pandemic influenza\u2013lessons from the 1918 virus","volume":"353","author":"Belshe","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2019.07.033_b0015","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3201\/eid1209.05-0979","article-title":"1918 Influenza: the mother of all pandemics","volume":"12","author":"Taubenberger","year":"2006","journal-title":"Emerg Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2019.07.033_b0020","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1093\/cid\/ciq012","article-title":"Estimating the burden of 2009 pandemic influenza A (H1N1) in the United States (April 2009-April 2010)","volume":"52","author":"Shrestha","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2019.07.033_b0025","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1128\/jb.89.1.170-174.1965","article-title":"Induction of partial specific heterotypic immunity in mice by a single infection with influenza a virus","volume":"89","author":"Schulman","year":"1965","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2019.07.033_b0030","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.4049\/jimmunol.152.4.1653","article-title":"Heterosubtypic immunity to influenza type-a virus in mice - effector mechanisms and their longevity","volume":"152","author":"Liang","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2019.07.033_b0035","doi-asserted-by":"crossref","first-page":"7437","DOI":"10.4049\/jimmunol.166.12.7437","article-title":"Heterosubtypic immunity to influenza A virus in mice lacking IgA, all Ig, NKT cells, or gamma delta T cells","author":"Benton","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2019.07.033_b0040","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJM198307073090103","article-title":"Cytotoxic T-cell immunity to influenza","volume":"309","author":"McMichael","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2019.07.033_b0045","doi-asserted-by":"crossref","first-page":"7578","DOI":"10.4049\/jimmunol.162.12.7578","article-title":"Human CD8+ and CD4+ T lymphocyte memory to influenza A viruses of swine and avian species","volume":"162","author":"Jameson","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2019.07.033_b0050","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/infdis\/jir436","article-title":"Live and inactivated influenza vaccines induce similar humoral responses, but only live vaccines induce diverse T-cell responses in young children","volume":"204","author":"Hoft","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.07.033_b0055","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/infdis\/151.1.81","article-title":"Cross-subtype protection in humans during sequential, overlapping, and\/or concurrent epidemics caused by H3N2 and H1N1 influenza viruses","volume":"151","author":"Sonoguchi","year":"1985","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.07.033_b0060","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1086\/498980","article-title":"Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature","volume":"193","author":"Epstein","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.07.033_b0065","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.vaccine.2010.10.064","article-title":"VennVax, a DNA-prime, peptide-boost multi-T-cell epitope poxvirus vaccine, induces protective immunity against vaccinia infection by T cell response alone","volume":"29","author":"Moise","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.07.033_b0070","doi-asserted-by":"crossref","first-page":"7052","DOI":"10.1128\/JVI.78.13.7052-7060.2004","article-title":"Protection against lethal vaccinia virus challenge in HLA-A2 transgenic mice by immunization with a single CD8+ T-cell peptide epitope of vaccinia and variola viruses","volume":"78","author":"Snyder","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.07.033_b0075","doi-asserted-by":"crossref","first-page":"5299","DOI":"10.1016\/j.vaccine.2009.06.101","article-title":"Epitope-based vaccination against pneumonic tularemia","volume":"27","author":"Gregory","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.07.033_b0080","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.4161\/hv.26511","article-title":"Immunization with cross-conserved H1N1 influenza CD4+ T-cell epitopes lowers viral burden in HLA DR3 transgenic mice","volume":"9","author":"Moise","year":"2013","journal-title":"Hum Vaccines Immunotherapeutics"},{"key":"10.1016\/j.vaccine.2019.07.033_b0085","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1080\/21645515.2015.1052197","article-title":"H7N9 T-cell epitopes that mimic human sequences are less immunogenic and may induce Treg-mediated tolerance","volume":"11","author":"Liu","year":"2015","journal-title":"Hum Vaccines Immunotherapeutics"},{"key":"10.1016\/j.vaccine.2019.07.033_b0090","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1038\/s41598-017-01372-5","article-title":"A humanized mouse model identifies key amino acids for low immunogenicity of H7N9 vaccines","volume":"7","author":"Wada","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2019.07.033_b0095","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1084\/jem.185.6.1113","article-title":"An HLA-DR1 transgene confers susceptibility to collagen-induced arthritis elicited with human type II collagen","volume":"185","author":"Rosloniec","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2019.07.033_b0100","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1084\/jem.185.12.2043","article-title":"HLA-A2.1-restricted education and cytolytic activity of CD8(+) T lymphocytes from beta2 microglobulin (beta2m) HLA-A2.1 monochain transgenic H-2Db beta2m double knockout mice","volume":"185","author":"Pascolo","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2019.07.033_b0105","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1002\/eji.200425463","article-title":"A mouse model of human adaptive immune functions: HLA-A2.1-\/HLA-DR1-transgenic H-2 class I-\/class II-knockout mice","volume":"34","author":"Pajot","year":"2004","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2019.07.033_b0110","first-page":"22","article-title":"GISAID: Global initiative on sharing all influenza data - from vision to reality","author":"Shu","year":"2017","journal-title":"Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin"},{"key":"10.1016\/j.vaccine.2019.07.033_b0115","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1128\/JVI.02005-07","article-title":"The influenza virus resource at the national center for biotechnology information","volume":"82","author":"Bao","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.07.033_b0120","doi-asserted-by":"crossref","first-page":"D571","DOI":"10.1093\/nar\/gku1207","article-title":"NCBI viral genomes resource","volume":"43","author":"Brister","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.vaccine.2019.07.033_b0125","doi-asserted-by":"crossref","first-page":"5740","DOI":"10.1016\/j.vaccine.2009.07.040","article-title":"Immunoinformatic comparison of T-cell epitopes contained in novel swine-origin influenza A (H1N1) virus with epitopes in 2008\u20132009 conventional influenza vaccine","volume":"27","author":"De Groot","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.07.033_b0130","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1080\/21645515.2015.1061159","article-title":"iVAX: An integrated toolkit for the selection and optimization of antigens and the design of epitope-driven vaccines","volume":"11","author":"Moise","year":"2015","journal-title":"Hum Vaccines Immunotherapeutics"},{"key":"10.1016\/j.vaccine.2019.07.033_b0135","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jhep.2014.08.026","article-title":"HCV epitope, homologous to multiple human protein sequences, induces a regulatory T cell response in infected patients","volume":"62","author":"Losikoff","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.vaccine.2019.07.033_b0140","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.4161\/hv.36134","article-title":"Immune camouflage: relevance to vaccines and human immunology","volume":"10","author":"De Groot","year":"2014","journal-title":"Human Vaccines Immunotherapeutics"},{"key":"10.1016\/j.vaccine.2019.07.033_b0145","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.4161\/hv.24615","article-title":"The two-faced T cell epitope: examining the host-microbe interface with JanusMatrix","volume":"9","author":"Moise","year":"2013","journal-title":"Hum Vaccines Immunotherapeutics"},{"key":"10.1016\/j.vaccine.2019.07.033_b0150","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1080\/21645515.2015.1061160","article-title":"An immunoinformatic approach for identification of Trypanosoma cruzi HLA-A2-restricted CD8(+) T cell epitopes","volume":"11","author":"Eickhoff","year":"2015","journal-title":"Hum Vaccines Immunotherapeutics"},{"key":"10.1016\/j.vaccine.2019.07.033_b0155","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1016\/j.vaccine.2005.01.097","article-title":"HIV vaccine development by computer assisted design: the GAIA vaccine","volume":"23","author":"De Groot","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.07.033_b0160","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/infdis\/jiy103","article-title":"A universal influenza vaccine: the strategic plan for the national institute of allergy and infectious diseases","volume":"218","author":"Erbelding","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.07.033_b0165","first-page":"6","article-title":"Harnessing the power of T cells: the promising hope for a universal influenza vaccine","author":"Clemens","year":"2018","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2019.07.033_b0170","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nri.2015.10","article-title":"The multifaceted role of CD4(+) T cells in CD8(+) T cell memory","volume":"16","author":"Laidlaw","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2019.07.033_b0175","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.4161\/hv.25598","article-title":"Universal H1N1 influenza vaccine development: identification of consensus class II hemagglutinin and neuraminidase epitopes derived from strains circulating between 1980 and 2011","volume":"9","author":"Moise","year":"2013","journal-title":"Hum Vaccines Immunotherapeutics"},{"key":"10.1016\/j.vaccine.2019.07.033_b0180","doi-asserted-by":"crossref","DOI":"10.4172\/1745-7580.1000043","article-title":"Immunogenic consensus sequence T helper epitopes for a pan-burkholderia biodefense vaccine","volume":"7","author":"De Groot","year":"2011","journal-title":"Immunome Res"},{"key":"10.1016\/j.vaccine.2019.07.033_b0185","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4161\/hv.2869","article-title":"Confirmation of immunogenic consensus sequence HIV-1 T-cell epitopes in Bamako, Mali and Providence, Rhode Island","volume":"2","author":"Koita","year":"2006","journal-title":"Hum Vaccines"},{"key":"10.1016\/j.vaccine.2019.07.033_b0190","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1016\/j.vaccine.2007.01.039","article-title":"Diversity of Francisella tularensis Schu4 antigens recognized by T lymphocytes after natural infections in humans: identification of candidate epitopes for inclusion in a rationally designed tularemia vaccine","volume":"25","author":"McMurry","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.07.033_b0195","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.vaccine.2007.10.061","article-title":"Safety and immunogenicity of cytotoxic T-lymphocyte poly-epitope, DNA plasmid (EP HIV-1090) vaccine in healthy, human immunodeficiency virus type 1 (HIV-1)-uninfected adults","volume":"26","author":"Gorse","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.07.033_b0200","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1128\/CVI.00492-07","article-title":"Clinical phase 1 testing of the safety and immunogenicity of an epitope-based DNA vaccine in human immunodeficiency virus type 1-infected subjects receiving highly active antiretroviral therapy","volume":"15","author":"Wilson","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2019.07.033_b0205","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00262-013-1516-5","article-title":"Immunologic response to the survivin-derived multi-epitope vaccine EMD640744 in patients with advanced solid tumors","volume":"63","author":"Lennerz","year":"2014","journal-title":"Cancer Immunol, Immunotherapy : CII"},{"key":"10.1016\/j.vaccine.2019.07.033_b0210","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1186\/1479-5876-11-291","article-title":"Phase I\/II clinical trial using HLA-A24-restricted peptide vaccine derived from KIF20A for patients with advanced pancreatic cancer","volume":"11","author":"Asahara","year":"2013","journal-title":"J Transl Med"},{"key":"10.1016\/j.vaccine.2019.07.033_b0215","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa0810097","article-title":"Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia","volume":"361","author":"Kenter","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2019.07.033_b0220","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(05)17945-8","article-title":"Effect of a p210 multipeptide vaccine associated with imatinib or interferon in patients with chronic myeloid leukaemia and persistent residual disease: a multicentre observational trial","volume":"365","author":"Bocchia","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2019.07.033_b0225","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature22991","article-title":"An immunogenic personal neoantigen vaccine for patients with melanoma","volume":"547","author":"Ott","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2019.07.033_b0230","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature23003","article-title":"Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer","volume":"547","author":"Sahin","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2019.07.033_b0235","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s10875-011-9632-5","article-title":"Safety and immunogenicity of multimeric-001\u2013a novel universal influenza vaccine","volume":"32","author":"Atsmon","year":"2012","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.vaccine.2019.07.033_b0240","doi-asserted-by":"crossref","first-page":"5816","DOI":"10.1016\/j.vaccine.2014.08.031","article-title":"Priming by a novel universal influenza vaccine (Multimeric-001)-a gateway for improving immune response in the elderly population","volume":"32","author":"Atsmon","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.07.033_b0245","doi-asserted-by":"crossref","first-page":"6542","DOI":"10.1128\/JVI.00641-13","article-title":"Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies","volume":"87","author":"Krammer","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.07.033_b0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024626","article-title":"Cross-protective peptide vaccine against influenza A viruses developed in HLA-A*2402 human immunity model","volume":"6","author":"Ichihashi","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.07.033_b0255","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.vaccine.2009.10.103","article-title":"Universal influenza DNA vaccine encoding conserved CD4+ T cell epitopes protects against lethal viral challenge in HLA-DR transgenic mice","volume":"28","author":"Alexander","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.07.033_b0260","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1182\/blood-2013-03-490565","article-title":"Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma","volume":"122","author":"Linette","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2019.07.033_b0265","doi-asserted-by":"crossref","first-page":"197ra03","DOI":"10.1126\/scitranslmed.3006034","article-title":"Identification of a Titin-derived HLA-A1-presented peptide as a cross-reactive target for engineered MAGE A3-directed T cells","volume":"5","author":"Cameron","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2019.07.033_b0270","doi-asserted-by":"crossref","first-page":"12241","DOI":"10.1128\/JVI.01563-08","article-title":"Immunomic analysis of the repertoire of T-cell specificities for influenza A virus in humans","volume":"82","author":"Assarsson","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.07.033_b0275","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/imm.12548","article-title":"Epitope specific T-cell responses against influenza A in a healthy population","volume":"147","author":"Savic","year":"2016","journal-title":"Immunology"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19309247?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19309247?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T13:31:37Z","timestamp":1778679097000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19309247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":55,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0264410X19309247"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.07.033","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Highly conserved influenza T cell epitopes induce broadly protective immunity","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.07.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}